Arcadia Biosciences Corp (RKDA) Price to Earnings Ratio

Arcadia Biosciences Inc - graphic logo of issuer RKDA

Arcadia Biosciences (RKDA) generates revenue from the sale of enriched pasta and flour under its own trademarks. This chart illustrating market price action reflects a standalone P/E ratio of -0.10. Meanwhile, the business relies critically on external contractors for processing and sowing, although it is currently seeking to increase its own elite wheat cultivation capacities by developing regional distribution networks.

RKDA: Arcadia Biosciences Price to Earnings Ratio 07/04/2022 - 11/15/2026

Comprehensive metric breakdowns and analytics for Arcadia Biosciences Corp (RKDA)

- price and consensus price forecast:
Stock Price Arcadia Biosciences Inc|RKDA - Price Target Chart
- market capitalization details:
Market Value Arcadia Biosciences Corp|RKDA - Real Price to Acquire Entire Company
- book capitalization information:
Book Price of a Share Arcadia Biosciences|RKDA - Company Net Assets|Market Capitalization to Book Value Ratio arcadiabio.com|RKDA - Aggregate Company Assets
- debt obligations and liquidity statistics:
All Debt to Shareholders' Equity Ratio Arcadia Biosciences|RKDA - Long-Term Debt to Capital|Short-Term Debt to Capital arcadiabio.com|RKDA - Company Debts|Debt to Book Capitalization Ratio Arcadia Biosciences Corp|RKDA - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Arcadia Biosciences|Intermediate Liquidity Ratio arcadiabio.com
- earnings and valuation multiples information:
RKDA - Net Profit|Expected Net Profit Arcadia Biosciences|RKDA - P/E Multiple|Projected Price to Earnings Arcadia Bio|RKDA - PEG Multiple|Business Value to Operating Income Before Depreciation Arcadia Bio|RKDA - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Arcadia Biosciences|RKDA - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months arcadiabio.com|RKDA - Earnings per share growth in current year|Net earnings per share growth forecast for next year Arcadia Biosciences
- issuer revenue and sales details:
RKDA - Company Revenue|Company Expected Sales Volume Arcadia Biosciences, Inc.|RKDA - P/S Multiple|Projected Price to Revenue Arcadia Biosciences Corp
Comprehensive company analysis:Arcadia Bio
Flagship merchandise of Arcadia Bio

The analyst assesses the resilience of Arcadia Biosciences (RKDA) to market downturns through the lens of its yield. Prolonged GMO certification cycles and a reliance on licensing deals create earnings volatility. The company's P/E trend reflects the ratio of the business's market value to its ability to generate net income. This multiple allows an investor to distinguish an overvalued asset from an undervalued enterprise. The precise balance of this metric confirms the reliability of the investment.

Competing companies

P/E Multiple IDEXX Laboratories|Price to Earnings Ratio Trimble Corp (TRMB)|Price to Earnings Ratio NEOG (Neogen Corporation)|Zhengye Bio - Price to Earnings Ratio|P/E Multiple Yimutian Inc YMT|BIOX: Price to Earnings Ratio|GRWG - P/E Multiple|RYM: P/E Multiple|Cibus Global - Company Value to Net Income|WFCF (Where Food Comes From Inc) - P/E Multiple|P/E Multiple ageagle.com|Price to Earnings Ratio The GrowHub (TGHL)|IPW (iPower Corp) - Company Value to Net Income|Hydrofarm Holdings - Price to Earnings Ratio|Market Price to Net Income Ratio BNC (Surna Inc.)|UGRO: Price to Earnings Ratio|n2off.com - Market Price to Net Income Ratio|AGRI: P/E Multiple|Market Cap to Earnings Agrify Corp (AGFY)|BHIL (Benson Hill Inc) - P/E Multiple|Price to Earnings Ratio Surna (CEAD)|Price to Earnings Ratio Tingo Group (TIO)